TENS Therapy Device

B2B contract manufacturing of clinical TENS therapy devices for rehabilitation clinics and hospital physical therapy suites. Features dual isolated constant-current channels, adjustable 10–100 us interphase interval (IPI), active 100V compliance rail, zero-DC capacitive output stages, and IEC 60601-2-10 compliance.

The TENS therapy device is a dual-channel, constant-current transcutaneous electrical nerve stimulator designed for hospital outpatient rehabilitation, orthopedic physical therapy departments, and multi-patient clinical environments. The console generates pulsed bi-directional electrical charges to activate afferent nerve pathways for post-surgical incisional analgesia, chronic axial musculoskeletal pain, and joint mobilization therapy.

Standard commercial TENS devices deployed in multi-patient clinical workflows display three physical failure modes:

• Charge-Cancellation from Zero-Interphase Waveforms: Standard biphasic stimulators reverse current polarity immediately after the negative phase ($t_{\text{interphase}} = 0$). In thick nerve fibers (Aβ mechanoreceptors), the rapid polarity reversal pulls migrating ions back across the membrane before the activation (m) gates of voltage-gated sodium channels can open. This forces the clinician to dial up the current, spilling charge into unmyelinated C-fibers and causing acute epidermal stinging.
• Electro-Osmotic Drying Under Continuous Wear: Prolonged electrical conduction forces water molecules to migrate toward the cathode via electro-osmosis. The skin beneath the anode dries out, driving contact resistance from 500 Ohm past 2,200 Ohm within 45 minutes. Open-loop constant-voltage devices lose delivered charge as resistance climbs, causing the analgesic effect to decay.
• Transformer Inductance Spikes Across Extended Lead Wires: In clinic environments where devices use 1.5-meter to 2.0-meter lead cables, fast-switching output bridges interact with cable inductance and transformer leakage inductance. The resulting inductive kickback generates voltage ringing (f > 20\ MHz) exceeding 150V, puncturing thin hydrogel layers and inducing micro-current skin burns.

This TENS therapy platform incorporates two transformer-isolated constant-current stages running on an active 100V compliance rail. The driver introduces a calibrated interphase interval (10 us to 100 us) between pulse phases to prevent sensory charge cancellation. A 100 kHz sensing network tracks tissue resistance shifts caused by electro-osmotic fluid movement, dynamically adjusting drive voltage to keep current delivery flat. Series metallized polypropylene capacitors isolate the output, restricting net DC offset below 0.005 uC per cycle. We contract-manufacture this console for medical equipment brands, clinical physiotherapy supply chains, and rehabilitation hardware distributors.

The manufacturing of this TENS therapy console takes place in ISO 13485-certified Class 8 cleanrooms. The circuit is structured on an industrial 4-layer FR-4 printed circuit board with partitioned copper zones isolating the digital microcontroller, the switch-mode boost power stage, and two independent high-voltage analog output sections.

The primary boost circuit uses a 200 kHz inductive flyback converter driven by a 32-bit ARM Cortex-M4 microcontroller. The boost stage converts low battery voltage into a compliance rail adjustable up to 100V. A closed-loop current sensing network samples current across 0.1% tolerance shunt resistors at 200 kHz. When a patient's transcutaneous resistance changes due to electro-osmotic fluid movement or perspiration (spanning 400 Ohm to 2,000 Ohm), the processor shifts the boost PWM duty cycle within 25 microseconds, holding the dialed milliampere output constant.

Each output stage features an H-bridge of discrete low-on-resistance MOSFETs driven by high-speed push-pull gate drivers. The firmware executes an active biphasic pulse train containing an adjustable interphase interval (IPI): a negative stimulating pulse (30 us to 400 us) is generated, followed by a high-impedance dead-time delay (10 us to 100 us) where all bridge switches remain off, and finally an active positive recovery pulse with an identical volt-second integral. Each terminal lead passes through a 250V-rated non-polar metallized polypropylene capacitor, physically blocking direct current and restricting net DC offset below 0.005 uC per cycle.

Channel-to-channel isolation is established through dual planar pulse transformers and high-speed optocouplers rated for 3,000V DC breakdown. Inter-channel capacitive coupling is restricted below 10 pF, keeping crosstalk leakage current below 5 uA. An active RC snubber network is wired in parallel across the transformer secondaries, damping inductive flyback spikes generated across 2.0-meter patient cables and keeping voltage overshoot below 5% of peak amplitude.

The enclosure is injection-molded from flame-retardant PC/ABS alloy (UL 94V-0) with an integrated elastomer perimeter gasket providing IP22 fluid ingress protection. Following surface-mount assembly, boards undergo automated optical inspection (AOI) followed by 100% automated test equipment (ATE) verification across a biological load matrix (200, 500, 1,000, 1,500, and 2,500 Ohm in parallel with 0.1 uF). Testing validates pulse rise times (tr < 1.0μs), interphase timing accuracy, and the 10-millisecond open-circuit cutoff response. The minimum contract manufacturing order is 5,000 units.

• Programmable Interphase Interval (IPI) Delay (Eliminating Early Sensory Charge Cancellation and Lowering Depolarization Thresholds) 

  Standard symmetrical biphasic stimulators reverse voltage polarity immediately after the initial negative phase. In peripheral nerve biophysics, this immediate transition introduces charge cancellation: the positive recharge phase arrives while voltage-gated sodium channels (Nav 1.6) along the Aβ axonal membrane are still transitioning into their open conformation. The reversing field pulls mobile sodium ions away from the outer pore before inward transmembrane flow can occur, suppressing action potential generation. To overcome this, operators must increase current amplitude, which drives charge into high-threshold pain fibers (C-fibers) and causes cutaneous stinging. Our device inserts an adjustable 10 us to 100 us interphase interval (IPI) between the stimulating and recovery phases. During this microsecond dead time, all bridge switches remain off, leaving the membrane capacitance charged long enough for sodium activation gates to open fully and propagate the action potential. Depolarization of large-diameter sensory fibers occurs at 20% to 30% lower current densities, producing comfortable parasthesia without cutaneous prickling.

   

• Active Snubber Networks for Cable Inductance Suppression (Damping 150V High-Frequency Ringing Spikes in Extended Clinic Cables) 

  In outpatient physical therapy clinics, stimulators are frequently set on carts or bedside stands using 1.5-meter to 2.0-meter leadwires. Long dual-core cables exhibit distributed series inductances of 1.5 to 3.5 uH. When the output stage switches off a 60 mA pulse in under 1.0 microsecond, the instantaneous current drop (dI/dt > 60 Aμs) excites a resonant circuit formed by the cable inductance and transformer leakage inductance:

  Vspike = -L ·dI/dt

  This generates high-frequency inductive kickback spikes exceeding 150V at frequencies between 20 MHz and 40 MHz. These transient spikes puncture the thin dielectric barrier of drying hydrogel pads, producing micro-arc sparks that burn the patient's epidermis. We eliminate inductive ringing by placing an active RC snubber network directly across the transformer secondary winding. The snubber circuit absorbs high-frequency flyback energy, damping voltage ringing down to less than 5% of nominal pulse amplitude within 200 nanoseconds. Output pulses remain flat-topped square waves into long cables, eliminating micro-arcing and radio-frequency noise.

   

• Dynamic Electro-Osmosis Tracking & 100V Compliance Scaling (Maintaining Constant Milliampere Delivery Across Dermal Dehydration)

  During multi-hour continuous stimulation protocols, continuous electrical current drives electro-osmotic fluid flow: mobile water molecules bound to hydrated sodium ions migrate toward the cathode, leaving the tissue under the anode progressively desiccated. Over a 60-minute session, this local dehydration drives transcutaneous resistance from 600 Ohm up to 2,000 Ohm. Standard 40V or 50V stimulators cannot overcome this load increase: compliance voltage clamps, and delivered current falls below the therapeutic threshold (I = V / R). Our platform integrates an active 100V inductive boost converter paired with a 200 kHz current-sense loop. When tissue desiccation increases circuit resistance, the microcontroller steps up the compliance rail within 25 microseconds, delivering the electromotive force required to hold output current at the user's setting. The dialed milliampere current remains flat across the entire treatment session, preventing the premature analgesic decay seen in uncompensated stimulators.

• Ergonomic Chassis Tooling, Touch Displays & Master Kitting : We supply custom injection tooling for handheld and cart-mounted consoles featuring rubberized grip overmolding, heavy-duty belt clips, and large-format high-contrast back-lit displays. Control interfaces can be customized with optical digital encoders, sealed membrane switches, or capacitive touchscreens operable with medical gloves. Firmware options include hidden clinician lockout menus, treatment adherence logging, and localized language packs. Finished consoles are packaged in clinician-grade EVA carry cases, industrial drop-tested cartons, or blister kits bundled with custom-branded leadwires and hydrogel electrode sets. 

   

• Two-Center Supply Chain Mechanics : High-precision SMT circuit placement, planar pulse transformer automated winding, MCU firmware programming, and primary board functional testing execute natively inside our primary China facility. Mechanical chassis injection molding, display module optical bonding, lithium-ion battery integration, 48-hour burn-in stress calibration, final cleanroom packaging, and global ocean container palletization route through our Vietnam hub, shielding international B2B buyers from regional medical device tariffs and Section 301 duties.

• ANSI/AAMI NS4 & IEC 60601-2-10 Electrical Rigor : Production master units undergo testing in accredited independent testing laboratories confirming strict compliance with ANSI/AAMI NS4 (Transcutaneous electrical nerve stimulators), IEC 60601-1 (Class II, Type BF applied parts), IEC 60601-1-2 (EMC Class B hospital standards), and IEC 60601-2-10. Output current ceilings (<100 mA peak into 1,000 Ohm), maximum phase energy limits (<300 mJ into 1,000 Ohm), and open-circuit cutoff boundaries (<10 ms) are interlocked in hardware. 

• MDSAP & ISO 13485 Certified Manufacturing Oversight : Surface-mount assembly lines, transformer winding suites, and calibration stations operate strictly under certified ISO 13485:2016 and MDSAP regulatory frameworks (covering US FDA 21 CFR 820, Health Canada, TGA Australia). Unbroken electronic Device History Records (DHR) trace every discrete power semiconductor, pulse transformer, and printed circuit board from incoming inspection reels to outbound master shipping cartons.

Physical therapy equipment distributors, hospital biomedical engineering leads, and clinical electrotherapy brand operators can request complete ANSI/AAMI NS4 electrical compliance dossiers, interphase interval timing oscillograms, and functional unbranded evaluation consoles with clinical leadwires and electrode packages. 

👉 [Request TENS Therapy Device Evaluation Consoles]

Hot Tags: tens therapy device, China tens therapy device manufacturers, suppliers, factory, Transcutaneous Electrical Nerve Stimulation TENS Machines, electrical stimulation nerve, TENS Machine, Electric Stimulator for Nerve Pain, TENS machine for osteoarthritis, TENS Therapy Machine